Christian A. Pogoda
Muenster, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Impact of enzyme replacement therapy and migalastat on left atrial strain and cardiomyopathy in patients with Fabry disease.
Journal: Frontiers in cardiovascular medicine
Published: May 16, 2023
Permanent pacing in a very long-term follow-up after orthotopic heart transplantation: A matter of when or why?
Journal: Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc
Published: April 10, 2022
Cardiac allograft vasculopathy in a long-term follow-up after heart transplantation: Role of remnant cholesterol in residual inflammation.
Journal: Cardiology journal
Published: November 25, 2021
Treatment of Fabry Disease management with migalastat-outcome from a prospective 24 months observational multicenter study (FAMOUS).
Journal: European heart journal. Cardiovascular pharmacotherapy
Published: December 02, 2020
Case Report: A Spinal Ischemic Lesion in a 24-Year-Old Patient With Fabry Disease.
Journal: Frontiers in immunology
Published: August 16, 2020
Classic and Novel Biomarkers as Potential Predictors of Ventricular Arrhythmias and Sudden Cardiac Death.
Journal: Journal of clinical medicine
Published: January 31, 2020
Treatment switch in Fabry disease- a matter of dose?
Journal: Journal of medical genetics
Published: January 20, 2020
Treatment of Fabry's Disease With Migalastat: Outcome From a Prospective Observational Multicenter Study (FAMOUS).
Journal: Clinical pharmacology and therapeutics
Published: December 09, 2019
Pacemaker lead infection and related bacteraemia caused by normal and small colony variant phenotypes of Bacillus licheniformis.
Journal: Journal of medical microbiology
Published: March 23, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026